Latest filing published 01 Jul 2026 for Aptose Biosciences Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Warren Whitehead (board member) discloses dealings in Aptose Biosciences Inc. to SEC (Form 4). The record holds 2 filings, for trades running from 21 June 2021 to 30 June 2026.
No open-market purchase appears, only 1 sale worth €43k.
Most recently, on 1 July 2026, the filings show a transaction in Aptose Biosciences Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations